Insulin resistance as a risk factor for subclinical atherosclerosis in rheumatoid arthritis

Egyptian Rheumatologist

Volumn 36, Issue 1, 2014, Pages 7-13

  El Sayed, Adel Mahmoud ^a   El Bakry, Samah A ^a   Mobasher, Sameh Abdelmotteleb ^a   El Rahman, Rehab Abd ^a   Abo Shady, Rania Ahmed ^a   Abaza, Nouran ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Atherosclerosis; Insulin resistance; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; STEROID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CAROTID ARTERY; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; DAS28; DISEASE ASSOCIATION; ECHOGRAPHY; HIGH RISK POPULATION;

EID: 84891088932     PISSN: 11101164     EISSN: 20902433     Source Type: Journal    
DOI: 10.1016/j.ejr.2013.08.003     Document Type: Article

References (39)

1. Goodson N., Symmons D. Rheumatoid arthritis in women: still associated with an increased mortality. Ann Rheum Dis 2002, 61:955-956.
2. Rinse T., Jacobsen B.K., Gran J.T., Haga H.J., Arnesen E. Total mortality is increased in rheumatoid arthritis. A 17year prospective study. Clin Rheumatol 2001, 20:123-127.
3. Solomon D.H., Karlson E.W., Rimm E.B., Cannuscio C.C., Mandl L.A., Manson J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307.
4. Fischer L.M., Schlienger R.G., Matter J.C.H., Jick H., Meier C.R. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004, 93:198-200.
5. Sattar N., McCarey D.W., Capell H., McInnes I.B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003, 108:2957-2963.
6. Del Rincon I., Freeman G.L., Haas R.W., O'Leary D.H., Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005, 52:3413-3423.
7. Yang Z., Chen M., Ellett J.D., Carter J.D., Brayman K.L., Nadler J.L. Inflammatory blockade improves human pancreatic islet function and viability. Am J Transplant 2005, 5:475-483.
8. Chen M., Yang Z.D., Smith K.M., Carter J.D., Nadler J.L. Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity. Diabetologia 2005, 48:486-495.
9. Parkash J., Chaudhry M.A., Rhoten W.B. Tumor necrosis factor-α-induced changes in insulin-producing beta-cells. Anat Rec A Discov Mol Cell Evol Biol 2005, 286:982-993.
10. Johan Groeneveld A.B., Beishuizen A., Visser F.C. Insulin a wonder drug in the critically ill?. Crit Care 2002, 6:102-105.
11. Delaunay F., Khan A., Cintra A., Davani B., Ling Z.C., Andersson A., et al. Pancreatic β-cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 1997, 100:2094-2098.
12. Lambillotte C., Gilon P., Henquin J.C. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 1997, 99:414-423.
13. Dessein P.H., Joffe B.I., Stanwix A.E., Christian B.F., Veller M. Glucocorticoids and insulin sensitivity in rheumatoid arthritis. J Rheumatol 2004, 31:867-874.
14. Wolfe F., Michaud K. Corticosteroids increase the risk of diabetes mellitus in rheumatoid arthritis and contribute to the risk of myocardial infarction and heart failure [abstract]. Ann Rheum Dis 2004, 63(Suppl. 1):495.
15. Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., Gabriel S.E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005, 52:722-732.
16. van Doornum S., McColl G., Wicks I.P. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?. Arthritis Rheum 2002, 46:862-873.
17. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Effect of glucocorticoids. Diabetes Care 2007, 30:318-324.
18. Hanley A.J.G., Williams K., Stern M.P., Haffner S.M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002, 25:1177-1184.
19. Pamuc O.N., Unlu E., Cakir N. Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. J Rheumatol 2006, 33:2447-2452.
20. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010, 69(9):1580-1588.
21. Prevoo M.L., Van 't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995 Jan, 38(1):44-48.
22. Aletaha D., Smolen J. Disease activity index (CDAI) a review of their usefulness and validity. The simplified disease activity index (SDAI) and the clinical in rheumatoid arthritis. Clin Exp Rheumatol. 2005, 23(5 Suppl 39):S100-S108.
23. Wallace T.M., Levy J.C., Mattews D.R. Use and abuse of HOMA modelling. Diabetes Care 2004, 27:1487-1495.
24. La Montagna G., Cacciapuoti F., Buono R., Manzella D., Mennillo G.A., Arciello A., et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diabetes Vasc Dis Res 2007, 4:130-135.
25. Homma S., Hirose N., Ishida H., Ishii T., Araki G. Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke 2001 Apr, 32(4):830-835.
26. Ferraz Amaro I., Díaz González F., González Juanatey C., González Gay M.A. Insulin resistance and rheumatoid arthritis. Reumatol Clin 2011, 7(2):124-129.
27. Lee J.W., Park Y.E., Cho M.R., Baek S.H., Kim G.T., Lee J.H., et al. Determinants of insulin resistance in patients with rheumatoid arthritis. J Korean Rheum Assoc 2009 Jun, 16(2):100-107.
28. Chung C.P., Oeser A., Solus J.F., Gebretsadik T., Shintani A., Avalos I., et al. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 2008, 58:2105-2112.
29. da Cunha V.R., Brenol C.V., Brenol J.C., Fuchs S.C., Arlindo E.M., Melo I.M., et al. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol 2012 May, 41(3):186-191.
30. Garcia Diaz Jde D., Lopez de Guzman A., Sivera Monzo L., Cuende Quintana E. Significance of the insulin resistance in vascular disease associated to rheumatoid arthritis. Med Clin 2008, 130:197-198.
31. Dessein P.H., Joffe B.I. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006, 54:2765-2775.
32. Dessein P.H., Norton G.R., Woodiwiss A.J., Joffe B.I., Solomon A. Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. J Rheumatol 2007, 34:681-688.
33. Shahin D., Eltoraby E., Mesbah A., Houssen M. Insulin resistance in early untreated rheumatoid arthritis patients. Clin Biochem 2010, 43(7-9):661-665.
34. Sahebari M., Goshayeshi L., Mirfeizi Z., Rezaieyazdi Z., Hatef M.R., Ghayour-Mobarhan M., et al. Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis. Sc World J 2011, 11:1195-1205.
35. Dessein P.H., Joffe B.I., Veller M.G., Stevens B.A., Tobias M., Reddi K., et al. Traditional and non-traditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005, 32:435-442.
36. Howard G., Sharrett A.R., Heiss G., Evans G.W., Chambless L.E., Riley W.A., et al. Carotid artery intima-media thickness distribution in general population as evaluated by B-mode ultrasound ARIC Investigators. Stroke 1993, 24:1297-1304.
37. Veller M.G., Fisher C.M., Nicolaides A.N., Renton S., Geroulakos G., Stafford N.J., et al. Measurement of the ultrasonic intima media complex thickness in normal subjects. J Vasc Surg 1993, 17:719-725.
38. Chambless L.E., Zhong M.M., Arnett D., Folsom A.R., Riley Y.A., Heiss G. Variability in B-mode ultrasound measurement in atherosclerosis risk in communities (ARIC) study. Ultrasound Med Biol 1996, 22:545-554.
39. Denarié N., Gariepy J., Chironi G., Massonneau M., Laskri F., Salomon J., et al. Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes. Atherosclerosis 2000, 148:297-302.